Dutch biotech developing thrombolytic treatments for thrombotic diseases.
| Date | Round | Amount |
|---|---|---|
| Mar 2022 | Series A Utrecht biotech TargED raised a 39M euro Series A from Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures. | $39M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.